Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -79.40% is in line with its 5-year average of -83.45%, near the high end of its 5-year range (-201.65%–-45.96%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.11% above its 12-month average of -83.68%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -79.40%.
RETURN ON INVESTED CAPITAL (ROIC)
-79.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-83.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-74.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-83.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-81.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+5.11%
CURRENT VS 3Y AVG
-7.22%
CURRENT VS 5Y AVG
+4.85%
CURRENT VS 10Y AVG
+3.08%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.80%
median of 694 covered companies
CURRENT VS SECTOR MEDIAN
-134.91%
vs the sector median at left
Pulse Biosciences, Inc.
Market Cap
$3.43B
Return on Invested Capital (ROIC)
-79.40%
TTM Avg
-83.68%
3Y Avg
-74.06%
5Y Avg
-83.45%
Market Cap
$3.43B
Return on Invested Capital (ROIC)
6.25%
TTM Avg
16.80%
3Y Avg
-7.33%
5Y Avg
-16.60%
Market Cap
$3.45B
Return on Invested Capital (ROIC)
-0.93%
TTM Avg
1.17%
3Y Avg
-16.63%
5Y Avg
-13.35%
Market Cap
$3.37B
Return on Invested Capital (ROIC)
-409.85%
TTM Avg
-257.76%
3Y Avg
-257.76%
5Y Avg
-257.76%
Market Cap
$3.54B
Return on Invested Capital (ROIC)
-1.07%
TTM Avg
-9.16%
3Y Avg
-22.10%
5Y Avg
-20.63%
Market Cap
$3.54B
Return on Invested Capital (ROIC)
-17.68%
TTM Avg
-22.74%
3Y Avg
-21.16%
5Y Avg
-18.86%
Market Cap
$3.54B
Return on Invested Capital (ROIC)
-28.15%
TTM Avg
-46.92%
3Y Avg
-38.64%
5Y Avg
-44.96%
Market Cap
$3.61B
Return on Invested Capital (ROIC)
-69.75%
TTM Avg
-63.60%
3Y Avg
-55.78%
5Y Avg
-83.39%
Market Cap
$3.14B
Return on Invested Capital (ROIC)
-50.82%
TTM Avg
-45.69%
3Y Avg
-35.19%
5Y Avg
-27.59%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulse Biosciences, Inc. (PLSE) | $3.43B | -79.40% | -83.68% | -74.06% | -83.45% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.43B | 6.25% | 16.80% | -7.33% | -16.60% |
| CareDx, Inc (CDNA)vs › | $3.45B | -0.93% | 1.17% | -16.63% | -13.35% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.37B | -409.85% | -257.76% | -257.76% | -257.76% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.54B | -1.07% | -9.16% | -22.10% | -20.63% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.54B | -17.68% | -22.74% | -21.16% | -18.86% |
| Celcuity Inc. (CELC)vs › | $3.54B | -28.15% | -46.92% | -38.64% | -44.96% |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.61B | -69.75% | -63.60% | -55.78% | -83.39% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.14B | -50.82% | -45.69% | -35.19% | -27.59% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.09B | 9.95% | -25.98% | -51.77% | -51.95% |
ROIC
-79.4%
ROE
-80.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -79.40% |
| 2026-03-31 | -108.66% |
| 2025-12-31 | -85.72% |
| 2025-09-30 | -79.69% |
| 2025-06-30 | -64.92% |
| 2025-03-31 | -50.70% |
| 2024-12-31 | -45.96% |
| 2024-09-30 | -56.23% |
| 2024-06-30 | -133.83% |
| 2024-03-31 | -101.23% |
| 2023-12-31 | -83.08% |
| 2023-09-30 | -65.75% |
| 2023-06-30 | -67.34% |
| 2023-03-31 | -78.63% |
| 2022-12-31 | -79.73% |
| 2022-09-30 | -80.23% |
| 2022-06-30 | -184.57% |
| 2022-03-31 | -201.65% |
| 2021-12-31 | -136.49% |
| 2021-09-30 | -104.50% |
| 2021-06-30 | -83.41% |
| 2021-03-31 | -78.37% |
| 2020-12-31 | -148.23% |
| 2020-09-30 | -114.75% |
| 2020-06-30 | -91.97% |
| 2020-03-31 | -173.92% |
| 2019-12-31 | -128.02% |
| 2019-09-30 | -96.48% |
| 2019-06-30 | -78.38% |
| 2019-03-31 | -65.71% |
| 2018-12-31 | -56.21% |
| 2018-09-30 | -128.44% |
| 2018-06-30 | -94.30% |
| 2018-03-31 | -73.46% |
| 2017-12-31 | -54.22% |
| 2017-09-30 | -38.39% |
| 2017-06-30 | -58.13% |
| 2017-03-31 | -40.75% |
| 2016-12-31 | -37.89% |
| 2016-09-30 | -29.71% |
| 2016-06-30 | -22.04% |
| 2016-03-31 | -44.43% |
| 2015-12-31 | -32.70% |
| 2015-09-30 | -21.52% |
